Stop TB Partnership

The Global Plan to End TB 2023-2030

- Released in

The Global Plan to End TB, 2023–2030 (Global Plan) is a plan for ending tuberculosis (TB) as a public health challenge by 2030—the year by which governments around the world have committed to achieving the United Nations (UN) Sustainable Development Goals. This document provides the most detailed costing estimates of any Global Plan to date and builds on the previous edition, Paradigm Shift, which laid out priority actions for 2018–2022 informed by global commitments endorsed by Member States at the 2018 UN High-Level Meeting (UNHLM) on TB.

TB screening in mountain and island villages in Viet Nam using artificial intelligence and ultra-portable x-ray

- Released in

This document is one of a series spotlighting the experiences of these early implementers when using artificial intelligence (AI) / computer-aided detection (CAD), to highlight the added value of CAD for TB programmes and inspire prospective implementers to innovate. Funding of this project was provided by the Stop TB Partnership’s TB REACH initiative, launched in 2010 by Global Affairs Canada. In 2012, TB REACH first worked with implementing partners to pilot CAD software.

Tuberculosis Research Funding Trends, 2005–2019

- Released in
For the second year, global funding for tuberculosis (TB) research and development (R&D) surpassed US$900 million—this time, just barely, with US$900,964,590 spent on TB R&D in 2019. An optimist would emphasize that this figure represents the second highest level of funding for TB research ever recorded by Treatment Action Group (TAG) and the Stop TB Partnership. A realist would point out that funding for TB R&D continues to fall more than halfway short of the US$2 billion per year called for in the political declaration of the 2018 United Nations High-Level Meeting on TB (UN HLM).

Step Up for TB 2020 - Tuberculosis Policies in 37 Countries

- Released in
This Step Up for TB 2020 report by the Stop TB Partnership and Médecins Sans Frontières (MSF) summarises findings from the 4th survey of national TB policies in the Step Up for TB series. This edition presents data on 37 high-burden countries (representing 77% of the global estimated TB incident cases), assessing the extent to which national policies align with international best practices based on WHO guidelines and the latest scientific research. It also reports on some of the barriers to policy adoption and implementation identified by NTPs, although it does not attempt to portray the level of implementation across all policies featured. It offers an insight into the ambitions of governments around the world regarding the care they aim to provide. These ambitions are considered in the context of countries’ global commitments and progress in implementation, as reported by WHO.

The Impact of COVID-19 on the TB Epidemic: A Community Perspective

- Released in
Tuberculosis (TB) is the world's leading infectious disease, killing around 1.5 million people each year. Despite global and national efforts to end TB and the availability of cost-effective medicines to treat and cure it, too many people continue to suffer from this old disease. In response to early warnings that COVID-19 was having a devastating impact on people affected by TB and TB programs around the world, 10 global networks quickly came together to take action.

The Global Plan To End TB 2018-2022

- Released in

The goal of the Global Plan is to provide a costed blueprint for actions that countries should take to fulfil the targets and commitments in the Political Declaration of the UNHLM on TB and to get on track to end TB as outlined in the WHO’s End TB Strategy and the SDGs.

Stop TB Partnership TB Stigma Assessment - Implementation Handbook

- Released in

Tuberculosis (TB) is curable but it still kills more people globally than any other single infectious disease. This is mainly due to challenges in accessing quality, affordable and equitable TB services and care. Millions of people affected by TB endure its hardships and manage to survive despite these barriers, which are driven by and heightened by TB stigma. Put simply, to end TB, we must end TB stigma.

Tuberculosis Research Funding Trends 2005-2018

- Released in
TAG’s latest report on global funding for TB research and development (R&D), published in collaboration with the Stop TB Partnership, presents new data on TB R&D funding in 2018 and analyzes trends in funding since 2005.